Sartorius Stedim Biotech SA
F:56S0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
F:56S0
|
FR |
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
IN |
Wall St Price Targets
56S0 Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for 56S0 is 23.51 EUR with a low forecast of 20.91 EUR and a high forecast of 27.38 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 56S0's stock price target?
Price Target
23.51
EUR
According to Wall Street analysts, the average 1-year price target for 56S0 is 23.51 EUR with a low forecast of 20.91 EUR and a high forecast of 27.38 EUR.
What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Sartorius Stedim Biotech SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 13%.
What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Pre-Tax Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 24%.
